243 related articles for article (PubMed ID: 36535520)
1. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
[TBL] [Abstract][Full Text] [Related]
2. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis and Mast Cell Disorders.
Gülen T; Akin C
Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
[TBL] [Abstract][Full Text] [Related]
5. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
6. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
7. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
8. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Primary Mast Cell Disorders in Anaphylaxis: Value of KIT D816V in Peripheral Blood.
De Puysseleyr LP; Ebo DG; Elst J; Faber MA; Poorten MV; Van Gasse AL; Bridts CH; Mertens C; Van Houdt M; Hagendorens MM; Verlinden A; Vermeulen K; Maes MB; Berneman ZN; Sabato V
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3176-3187.e3. PubMed ID: 33975032
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis.
Kristensen T; Vestergaard H; Bindslev-Jensen C; Mortz CG; Kjaer HF; Ollert M; Møller MB; Broesby-Olsen S;
Allergy; 2017 Nov; 72(11):1737-1743. PubMed ID: 28432683
[TBL] [Abstract][Full Text] [Related]
11. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
Zaghmout T; Maclachlan L; Bedi N; Gülen T
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
[TBL] [Abstract][Full Text] [Related]
12. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
13. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
[TBL] [Abstract][Full Text] [Related]
15. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
[TBL] [Abstract][Full Text] [Related]
16. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
[TBL] [Abstract][Full Text] [Related]
17. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes.
Navarro-Navarro P; Álvarez-Twose I; Pérez-Pons A; Henriques A; Mayado A; García-Montero AC; Sánchez-Muñoz L; González-López O; Matito A; Caldas C; Jara-Acevedo M; Orfao A
Allergy; 2023 May; 78(5):1347-1359. PubMed ID: 36385619
[TBL] [Abstract][Full Text] [Related]
18. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
Thomas EG; Thomas DJ
Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
[TBL] [Abstract][Full Text] [Related]
19. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.
Broesby-Olsen S; Kristensen T; Vestergaard H; Brixen K; Møller MB; Bindslev-Jensen C;
J Allergy Clin Immunol; 2013 Sep; 132(3):723-728. PubMed ID: 23587333
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes.
Gonzalez-de-Olano D; Álvarez-Twose I
Curr Allergy Asthma Rep; 2024 Feb; 24(2):25-32. PubMed ID: 38270805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
